source
- Caldera Therapeutics merges with Synlogic, secures $278M to advance inflammation drugCaldera Therapeutics, a startup founded seven months ago with $112.5 million of venture funding, announced a merger with Synlogic, a company that previously went public via a reverse merger. The a…
- Opinion: STAT+: Dementia finally has a business modelThe big takeaway from the recent Alzheimer’s Association International Conference in London is an economic message: Dementia finally has a business model, writes Jason Karlawish.